Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 99464-64-9
2. Flucam
3. Cp 65703
4. Ampiroxicamum
5. Cp-65703
6. Ethyl 1-{[2-methyl-1,1-dioxido-3-(pyridin-2-ylcarbamoyl)-2h-1,2-benzothiazin-4-yl]oxy}ethyl Carbonate
7. Nsc-759807
8. 0pv32jzb1j
9. Chebi:31210
10. Carbonic Acid, Ethyl 1-((2-methyl-3-((2-pyridinylamino)carbonyl)-2h-1,2-benzothiazin-4-yl)oxy)ethyl Ester, S,s-dioxide
11. Ncgc00164605-01
12. Cp-65,703
13. Dsstox_cid_26474
14. Dsstox_rid_81645
15. Dsstox_gsid_46474
16. Ampiroxicamum [latin]
17. Nacyl
18. Ethyl (1-((2-methyl-1,1-dioxido-3-(pyridin-2-ylcarbamoyl)-2h-benzo[e][1,2]thiazin-4-yl)oxy)ethyl) Carbonate
19. Cas-99464-64-9
20. Unii-0pv32jzb1j
21. Brn 5184713
22. Ampiroxicam [inn:ban:jan]
23. Ampiroxicam- Bio-x
24. Flucam (tn)
25. Ampiroxicam [mi]
26. Ampiroxicam [inn]
27. Ampiroxicam [jan]
28. Ampiroxicam (jp17/inn)
29. Ampiroxicam [mart.]
30. Schembl49363
31. Ampiroxicam [who-dd]
32. Mls001424306
33. Chembl1566249
34. Dtxsid6046474
35. Schembl21357883
36. Ampiroxicam, >=98% (hplc)
37. Hms2052j03
38. Hms2090i13
39. Hms2232l11
40. Hms3372k07
41. Hms3394j03
42. Hms3652m15
43. Hms3715n12
44. Hms3885a18
45. Pharmakon1600-01504830
46. Bcp13545
47. Tox21_112227
48. Nsc759807
49. S4011
50. Akos015900478
51. Tox21_112227_1
52. Ccg-101155
53. Ccg-213956
54. Nc00405
55. Nsc 759807
56. Ncgc00164605-02
57. (+-)-4-(1-hydroxyethoxy)-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide Ethyl Carbonate (ester), 1,1-dioxide
58. Ac-18891
59. Ac-32693
60. As-56304
61. Ba164172
62. Ethyl 1-[[2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)-1lambda6,2-benzothiazin-4-yl]oxy]ethyl Carbonate
63. Hy-17484
64. Smr000469285
65. Db-057785
66. Ft-0602844
67. Sw219542-1
68. C77384
69. D01397
70. Ab00698363-05
71. Ab00698363_06
72. Ab00698363_07
73. 464a649
74. Sr-01000763537
75. Q3614672
76. Sr-01000763537-3
77. Brd-a39172021-001-06-1
78. Methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]oct-3-ene-4-carboxylate
79. (+/-)-4-(1-hydroxyethoxy)-2-methyl-n-2-pyridyl-2h-1,2-benzothiazine-3-carboxamide Ethyl Carbonate (ester), 1,1-dioxide
80. 4-[1-(ethoxycarbonyloxy)ethoxy]-2-methyl-n-(2-pyridyl)-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide
81. Carbonic Acid Ethyl 1-({2-methyl-3-[(2-pyridinylamino)carbonyl]-2h-1,2-benzothiazin-4-yl}oxy)ethyl Ester S,s-dioxide
82. Ethyl 1-([2-methyl-1,1-dioxido-3-[(2-pyridinylamino)carbonyl]-2h-1,2-benzothiazin-4-yl]oxy)ethyl Carbonate
83. Ethyl 1-[[2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)-1$l^{6,2-benzothiazin-4-yl]oxy]ethyl Carbonate
| Molecular Weight | 447.5 g/mol |
|---|---|
| Molecular Formula | C20H21N3O7S |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 8 |
| Exact Mass | 447.11002119 g/mol |
| Monoisotopic Mass | 447.11002119 g/mol |
| Topological Polar Surface Area | 133 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 808 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Ampiroxicam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ampiroxicam, including repackagers and relabelers. The FDA regulates Ampiroxicam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ampiroxicam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ampiroxicam supplier is an individual or a company that provides Ampiroxicam active pharmaceutical ingredient (API) or Ampiroxicam finished formulations upon request. The Ampiroxicam suppliers may include Ampiroxicam API manufacturers, exporters, distributors and traders.
click here to find a list of Ampiroxicam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ampiroxicam Drug Master File in Japan (Ampiroxicam JDMF) empowers Ampiroxicam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ampiroxicam JDMF during the approval evaluation for pharmaceutical products. At the time of Ampiroxicam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ampiroxicam suppliers with JDMF on PharmaCompass.
Ampiroxicam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ampiroxicam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ampiroxicam GMP manufacturer or Ampiroxicam GMP API supplier for your needs.
A Ampiroxicam CoA (Certificate of Analysis) is a formal document that attests to Ampiroxicam's compliance with Ampiroxicam specifications and serves as a tool for batch-level quality control.
Ampiroxicam CoA mostly includes findings from lab analyses of a specific batch. For each Ampiroxicam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ampiroxicam may be tested according to a variety of international standards, such as European Pharmacopoeia (Ampiroxicam EP), Ampiroxicam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ampiroxicam USP).
LOOKING FOR A SUPPLIER?
